Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Short-term Investments (2022 - 2025)

Agilon Health's Short-term Investments history spans 4 years, with the latest figure at $111.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 47.37% year-over-year to $111.4 million; the TTM value through Dec 2025 reached $111.4 million, down 47.37%, while the annual FY2025 figure was $111.4 million, 47.37% down from the prior year.
  • Short-term Investments reached $111.4 million in Q4 2025 per AGL's latest filing, down from $139.2 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $422.5 million in Q1 2023 to a low of $111.4 million in Q4 2025.
  • Average Short-term Investments over 4 years is $292.4 million, with a median of $291.6 million recorded in 2024.
  • Peak YoY movement for Short-term Investments: skyrocketed 36.23% in 2023, then plummeted 47.37% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $411.9 million in 2022, then decreased by 7.56% to $380.8 million in 2023, then crashed by 44.39% to $211.7 million in 2024, then tumbled by 47.37% to $111.4 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Short-term Investments are $111.4 million (Q4 2025), $139.2 million (Q3 2025), and $155.6 million (Q2 2025).